
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Jun 23
Feb 23
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read MoreCutting-edge technologies are increasingly improving pharma’s R&D processes, which will reduce costs and, in turn, benefit patients, says Gunjan Bhardwaj. It’s no secret that drug prices are a controversial issue. Just last week, US President Trump called high drug prices an “injustice” and vowed to make the issue a priority for his administration. In the …
How AI, blockchain, and big data can reduce drug development costs Pharmaphorum Read More »
Post Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. I recently wrote about five technologies that are shaping the future of healthcare. One of these technologies — artificial intelligence — holds particular potential for improving medical care at the clinical level. Thanks to the digital revolution, medical professionals don’t …
Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as Chief Executive Officer of Innoplexus, Americas, further strengthening its leadership team. Lawrence is widely respected as exceptional team builder and accomplished leader in Pharma Industry. His addition to leadership team …
Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as Chief Executive Officer of Innoplexus, Americas, further strengthening its leadership team. Lawrence is widely respected as exceptional team builder and accomplished leader in Pharma Industry. His addition to leadership team …
Innoplexus AG proudly announces that our founder and CEO, Dr Gunjan Bhardwaj will be on the panel discussion at Machine Intelligence Summit to be held on 14th July 2017, in Berlin, Germany. The panel discussion is around “From Past Learning to Predictive Future” at 13:45 CET on Friday at Deutsche Telekom Hauptstadtrepräsentanz Französische Straße 33a-c, …
Innoplexus @ Machine Intelligence Summit, Berlin 2017 Read More »
As Kevin Rands, (a contributor at CIO.com) has stated in his blog “Data is the lifeline of any business”, and truly said, it remains the heart of businesses for life sciences and pharmaceutical industries. A lot still relies upon data while conducting research which is mostly done through traditional methods. As many top notch business …
Accelerating innovation in Pharma with Artificial Intelligence & Big Data Read More »
Innoplexus unveiled iPlexus at Bio-IT, 2017, Boston. iPlexus.ai is an end-to-end platform for Life Sciences which leverages Artificial Intelligence (AI) to cut the drug development time, from synthesis to approval, significantly. It generates continuous intelligence and insights, across discovery, clinical development, regulatory and commercial stages of drug development, spanning all major therapeutic areas and indications. …
Innoplexus Proudly Announces the Launch of its Product iPlexus, at Bio-IT World, 2017 Read More »
3 Ways Big Data and Analytics are Making Big Changes in Healthcare The technologies behind the next wave in healthcare innovation. Information is the new currency of innovation. With data flowing from countless new sources every day, the opportunities to dig in and learn more about the world around us have never been greater. Sometimes …
Innoplexus talks about Cybersecurity with Entrepreneur.com Are Indian Tech Start-ups Robust Enough To Run Fast With Nation’s Digital Drive? The Zomato security breach puts a question mark on the information handling ability of start-ups The digital drive in India has altered the functioning of the industrial sector and put it on a fast track. In …
Innoplexus talks about Cybersecurity with Entrepreneur.com Read More »